As the delta variant threatens to destabilize US economic activity via a possible 4th wave the leveraged loan pipeline has seen an uptick as issuers move to bring deals to market before Labor Day.
Over US$224bn of leveraged deals hit the pipeline in July, of which US$66.3bn was recorded in the last week of the month. The calendar includes US$7.8bn of secured and unsecured bridge loans that are part of the US$30bn LBO of Medline by private equity firms Blackstone, the Carlyle Group and Hellman & Friedman.
Meanwhile, over US$66bn of leveraged deal volume closed in July , up 62.3% from year ago levels, bringing 2021 leveraged loan volume to date to US$722bn, up 63% from US$442.4bn year over year. The shift in supply demand dynamics could precipitate a late summer shift in market sentiment in favor of investors on pricing and deal terms.
Latest news
Software, consumer-related direct lending deals fell in H1'26
The software and technology sector, the second-most-active sector in 2025 at 17% of total deal activity, slid to fifth place in the first half of 2026.
Unconquered Territory
With most of the map still unexplored, there’s room for a sequel.
